Biotech Values

[biotech_researcher]

“In cases like this, it’s rare for a merger not to pass because shareholders who are unhappy with the deal tend to sell their shares before the record date for the vote.”

Dew, you were spot on with your assumption that disgruntled shareholders typically just sell there shares. BMY has dropped $4.50 over the past 30 days..